GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Peptron Inc (XKRX:087010) » Definitions » Beneish M-Score

Peptron (XKRX:087010) Beneish M-Score : -3.24 (As of Jun. 08, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Peptron Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.24 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Peptron's Beneish M-Score or its related term are showing as below:

XKRX:087010' s Beneish M-Score Range Over the Past 10 Years
Min: -4.83   Med: -1.86   Max: 0.53
Current: -3.24

During the past 10 years, the highest Beneish M-Score of Peptron was 0.53. The lowest was -4.83. And the median was -1.86.


Peptron Beneish M-Score Historical Data

The historical data trend for Peptron's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peptron Beneish M-Score Chart

Peptron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.20 -1.97 -1.80 0.53 -2.90

Peptron Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.84 -2.41 -3.05 -2.90 -3.24

Competitive Comparison of Peptron's Beneish M-Score

For the Biotechnology subindustry, Peptron's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peptron's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Peptron's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Peptron's Beneish M-Score falls into.



Peptron Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Peptron for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1096+0.528 * 0.9344+0.404 * 1.4287+0.892 * 0.6332+0.115 * 1.6378
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.5102+4.679 * -0.102128-0.327 * 1.5503
=-3.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₩2,529 Mil.
Revenue was 477.267 + 799.672 + 683.466 + 695.353 = ₩2,656 Mil.
Gross Profit was 76.195 + 379.629 + 234.202 + 238.855 = ₩929 Mil.
Total Current Assets was ₩5,980 Mil.
Total Assets was ₩49,909 Mil.
Property, Plant and Equipment(Net PPE) was ₩38,399 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩2,785 Mil.
Selling, General, & Admin. Expense(SGA) was ₩2,708 Mil.
Total Current Liabilities was ₩8,166 Mil.
Long-Term Debt & Capital Lease Obligation was ₩4,520 Mil.
Net Income was -4030.646 + -3261.833 + -4140.301 + -4508.114 = ₩-15,941 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0 Mil.
Cash Flow from Operations was -2902.611 + -1359.852 + -3189.134 + -3392.135 = ₩-10,844 Mil.
Total Receivables was ₩3,599 Mil.
Revenue was 1163.402 + 793.234 + 1227.516 + 1009.873 = ₩4,194 Mil.
Gross Profit was 287.893 + 328.268 + 370.722 + 383.788 = ₩1,371 Mil.
Total Current Assets was ₩18,988 Mil.
Total Assets was ₩63,929 Mil.
Property, Plant and Equipment(Net PPE) was ₩39,983 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩4,980 Mil.
Selling, General, & Admin. Expense(SGA) was ₩2,832 Mil.
Total Current Liabilities was ₩10,422 Mil.
Long-Term Debt & Capital Lease Obligation was ₩59 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2528.732 / 2655.758) / (3599.05 / 4194.025)
=0.95217 / 0.858137
=1.1096

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1370.671 / 4194.025) / (928.881 / 2655.758)
=0.326815 / 0.349761
=0.9344

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5980.159 + 38399.354) / 49909.457) / (1 - (18988.277 + 39982.972) / 63929.291)
=0.1108 / 0.077555
=1.4287

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2655.758 / 4194.025
=0.6332

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4979.8 / (4979.8 + 39982.972)) / (2784.982 / (2784.982 + 38399.354))
=0.110754 / 0.067622
=1.6378

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2708.286 / 2655.758) / (2832.032 / 4194.025)
=1.019779 / 0.675254
=1.5102

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4519.571 + 8165.812) / 49909.457) / ((58.907 + 10422.209) / 63929.291)
=0.254168 / 0.163949
=1.5503

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-15940.894 - 0 - -10843.732) / 49909.457
=-0.102128

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Peptron has a M-score of -3.24 suggests that the company is unlikely to be a manipulator.


Peptron Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Peptron's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Peptron (XKRX:087010) Business Description

Traded in Other Exchanges
N/A
Address
37-24, Yuseong-daero 1628 beon-gil, Yuseong-gu, Daejeon, KOR, 305811
Peptron Inc is a biotechnology company engaged in developing fundamental technologies for peptide-based medicines. Its technology includes PeptrEX and SmartDepot. PeptrEX is an automatic system, enabling to synthesize simultaneously from a few to hundred types of peptides. SmartDepot is a proprietary ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of the drug. The group's research and development products include Luphere Depot for the treatment of prostate cancer and endometriosis, SR Exenatide PT302 AND SR EXENATIDE PT304 for the treatment of type II diabetes, SR Exenatide PT320 and 330 for the treatment of Parkinson's and Alzheimer's disease and SR Octreotide for the treatment of acromegaly and carcinoid tumor.

Peptron (XKRX:087010) Headlines

No Headlines